Cargando…
Letrozole treatment of adult female mice results in a similar reproductive phenotype but distinct changes in metabolism and the gut microbiome compared to pubertal mice
BACKGROUND: A majority of women with polycystic ovary syndrome (PCOS) have metabolic dysfunction that results in an increased risk of type 2 diabetes. We previously developed a pubertal mouse model using the aromatase inhibitor, letrozole, which recapitulates many of the reproductive and metabolic f...
Autores principales: | Torres, Pedro J., Skarra, Danalea V., Ho, Bryan S., Sau, Lillian, Anvar, Arya R., Kelley, Scott T., Thackray, Varykina G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419356/ https://www.ncbi.nlm.nih.gov/pubmed/30871463 http://dx.doi.org/10.1186/s12866-019-1425-7 |
Ejemplares similares
-
Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome
por: Arroyo, Pablo, et al.
Publicado: (2019) -
The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome
por: Kelley, Scott T., et al.
Publicado: (2016) -
Constitutively Active FOXO1 Diminishes Activin Induction of Fshb Transcription in Immortalized Gonadotropes
por: Park, Chung Hyun, et al.
Publicado: (2014) -
MON-204 Gut Bacterial Composition Correlates with an Improved PCOS Phenotype after Co-Housing
por: Thackray, Varykina, et al.
Publicado: (2019) -
Metagenome-Assembled Genomes from Murine Fecal Microbiomes Dominated by Uncharacterized Bacteria
por: Rastegar, Kiarash, et al.
Publicado: (2023)